Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Randomized Open Label Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of DermaBind TL, a Placental Membrane Allograft Intended for Use in the Management of Non-Healing Ulcers

NCT07172893 is registered in ClinicalTrials.gov with HealthTech Wound Care as lead sponsor.

NCT NCT07172893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07172893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Randomized Open Label Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of DermaBind TL, a Placental Membrane Allograft Intended for Use in the Management of Non-Healing Ulcers
Lead sponsor
HealthTech Wound Care
Phase
Phase 4
Overall status
Recruiting
Start date
December 10, 2025
Completion date
May 21, 2027
Enrollment
150 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu), venous leg ulcer (vlu)